Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03276390 · ClinicalTrials.gov registry record · NA
A Culturally Targeted Transplant Program
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 11,836
- Enrollment target
NCT03276390: Completed NA study, sponsored by Northwestern University.
NCT03276390 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 11,836 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (744% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03276390, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,836 participants
- Enrollment target
Study Summary
Hispanic/Latino patients with end-stage renal disease are disproportionately less likely to get a kidney transplant, and specifically, a living donor kidney transplant (LDKT), compared to non-Hispanic whites. Accordingly, without LDKTs, Hispanics experience longer transplant waiting times, shorter patient and graft survival, and worse quality of life. Cultural beliefs and linguistic barriers contribute to the disparity in LDKTs. The objective of the proposed study is to implement and evaluate Northwestern Medicine's® Hispanic Kidney Transplant Program, a culturally-competent transplant center-based intervention, at two transplant centers serving large Hispanic populations. The proposed study will provide valuable knowledge about the potential to rapidly disseminate the HKTP as a novel approach to increase Hispanic LDKTs nationally.
Primary Outcome
A center-level variable. This is a metric of disparity
Interventions
- BEHAVIORAL Hispanic Kidney Transplant Program (HKTP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,836 participants |
| Start Date | 2017-01-18 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
What the finished NCT03276390 record still lists
NCT03276390 is an interventional study that assigns participants to a tested intervention. Its 11,836 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (744% higher).
The record links to 0 conditions, and to 1 intervention - of which Hispanic Kidney Transplant Program (HKTP) is the first listed.
NCT03276390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03276390 about?
NCT03276390 is a clinical study titled "A Culturally Targeted Transplant Program". Hispanic/Latino patients with end-stage renal disease are disproportionately less likely to get a kidney transplant, and specifically, a living donor kidney transplant (LDKT), compared to non-Hispanic whites. Accordingly, without LDKTs, Hispanics experience longer transplant waiting times, shorter p...
What is the current status of trial NCT03276390?
This trial is currently completed. It is a NA study. The enrollment target is 11,836 participants. The study started on 2017-01-18. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT03276390?
The interventions under investigation include: Hispanic Kidney Transplant Program (HKTP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03276390?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03276390's enrollment target sits among peer trials
11,836 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07064473 · 11,800 participants · Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI